However, in PBMCs from asthma patients the increase in IFNγ correlated significantly with IL-2 (ρ = 0.648 p<0.05), but not with IL4 or IL-13, showing a Th1 dominant shift in response to sitostanol. The gene discussed is IL2; the disease is asthma.